摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

草酸氢铵(一水) | 1113-38-8

中文名称
草酸氢铵(一水)
中文别名
一水合草酸氢铵乙二酸氢铵
英文名称
ammonium hydrogen oxalate
英文别名
ammonium oxalate;diammonium oxalate;Azanium;hydron;oxalate
草酸氢铵(一水)化学式
CAS
1113-38-8;5972-72-5
化学式
C2H2O4*H3N
mdl
——
分子量
107.066
InChiKey
AJGPQPPJQDDCDA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    222-224°C
  • 沸点:
    230.85°C (rough estimate)
  • 密度:
    1.5000
  • 溶解度:
    水(轻微,超声处理)
  • 稳定性/保质期:

    有毒!

    可溶于,难溶于乙醇

计算性质

  • 辛醇/水分配系数(LogP):
    -0.68
  • 重原子数:
    7
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    75.6
  • 氢给体数:
    3
  • 氢受体数:
    5

安全信息

  • 危险品标志:
    Xn
  • 安全说明:
    S24/25
  • 危险类别码:
    R21/22
  • WGK Germany:
    1
  • 海关编码:
    2917119000
  • 危险品运输编号:
    UN 1759 8/PG 3
  • RTECS号:
    RO2750000
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335

SDS

SDS:e41fc2925b55f4296101e06399fe8e77
查看
Name: Ammonium oxalate monohydrate p.a. Material Safety Data Sheet
Synonym: Diammonium oxalate, monohydrate; Ethanedioic acid, diammonium salt monohydrate; Oxalic acid, diammonium salt monohydrate
CAS: 1113-38-8
Section 1 - Chemical Product MSDS Name:Ammonium oxalate monohydrate p.a. Material Safety Data Sheet
Synonym:Diammonium oxalate, monohydrate; Ethanedioic acid, diammonium salt monohydrate; Oxalic acid, diammonium salt monohydrate

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS
CAS# Chemical Name content EINECS#
1113-38-8 Ammonium oxalate anhydrous - 214-202-3
Hazard Symbols: XN
Risk Phrases: 21/22

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation. May result in corneal injury.
Skin:
Harmful if absorbed through the skin. Oxalate is an irritant and may cause dermatitis. Skin lesions begin with epithelial cracking and the formation of slow-healing ulcers. The fingers may appear cyanotic.
Ingestion:
Ulcerations of the mouth, vomiting of blood, and rapid appearance of shock, convulsions, twitching, tetany, and cardiovascular collapse may occur following ingestion of oxalic acid or its soluble salts.
Systemic effects may be due to formation of calcium oxalate which is insoluble at physiological pH and can be deposited in the brain and kidney tubules. Resultant hypocalcemia might disturb the function of the heart and nerves. Mean lethal dose for oxalates in adults is estimated at 10 - 30 grams (143 - 428 mg/kg).
Inhalation:
Inhalation of oxalic acid produces irritation of the respiratory tract, ulceration of the mucous membranes, headaches, nervousness, cough, vomiting, emaciation, back pain (due to kidney injury), and weakness.
Chronic:
Inhalation of oxalic acid dust or mist over a long period of time might result in weight loss and respiratory tract inflammation. Rats administered oxalic acid at 2.5 and 5% in the diet for 70 days developed depressed thyroid function and weight loss. A study of railroad car cleaners in Norway who were heavily exposed to oxalic acid solutions and vapors revealed a 53% prevalence of urolithiasis (the formation of urinary stones), compared to a rate of 12% among unexposed workers from the same company.

Section 4 - FIRST AID MEASURES
Eyes: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes. Get medical aid immediately.
Skin:
In case of contact, immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Get medical aid immediately. Wash clothing before reuse.
Ingestion:
If swallowed, do NOT induce vomiting. Get medical aid immediately.
If victim is fully conscious, give a cupful of water. Never give anything by mouth to an unconscious person.
Inhalation:
If inhaled, remove to fresh air. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.
Antidote: Intravenous administration of calcium gluconate or calcium chloride may be required if hypocalcemia or hypocalcemic tetany occur.

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or appropriate foam.

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Minimize dust generation and accumulation. Do not get in eyes, on skin, or on clothing. Keep container tightly closed.
Do not ingest or inhale. Discard contaminated shoes. Use only with adequate ventilation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Oxalates slowly corrode steel.

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary.

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Appearance: white
Odor: odorless
pH: 6.4 @ 0.1M
Vapor Pressure: Not applicable.
Viscosity: Not available.
Boiling Point: Decomposes.
Freezing/Melting Point: 70 deg C (dec)
Autoignition Temperature: Not applicable.
Flash Point: Not applicable.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature: 70 deg C
Solubility in water: Soluble.
Specific Gravity/Density: 1.5
Molecular Formula: C2H8N2O4.H2O
Molecular Weight: 142.11

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Dust generation, excess heat, Oxalates slowly corrode steel..
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and gases, carbon dioxide, formic acid, ammonia.
Hazardous Polymerization: Has not been reported.

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 1113-38-8: RO2750000 CAS# 6009-70-7 unlisted.
LD50/LC50:
Not available.
Not available.
Carcinogenicity:
Ammonium oxalate anhydrous - Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Ammonium oxalate, monohydrate - Not listed by ACGIH, IARC, NIOSH, NTP, or OSHA.
Other:
See actual entry in RTECS for complete information.

Section 12 - ECOLOGICAL INFORMATION


Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
IMO
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2811
Packing Group: III
RID/ADR
Shipping Name: TOXIC SOLID, ORGANIC, N.O.S.
Dangerous Goods Code: 6.1(25C)
UN Number: 2811

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 21/22 Harmful in contact with skin and if
swallowed.
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
WGK (Water Danger/Protection)
CAS# 1113-38-8: No information available.
CAS# 6009-70-7: 1
United Kingdom Occupational Exposure Limits
Canada
CAS# 1113-38-8 is listed on Canada's DSL List.
CAS# 1113-38-8 is not listed on Canada's Ingredient Disclosure List.
CAS# 6009-70-7 is not listed on Canada's Ingredient Disclosure List.
Exposure Limits
US FEDERAL
TSCA
CAS# 1113-38-8 is listed on the TSCA inventory.
CAS# 6009-70-7 is not on the TSCA Inventory. It is a hydrate and
exempt from TSCA Inventory requirements (40CFR720.3(u)(2)).


SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

理化性质

草酸铵化学式为 $(\text{NH}_4)_2\text{C}_2\text{O}_4·\text{H}_2\text{O}$。其分子量为 142.11。无色柱状或白色粒状结晶,有毒。没有确切的熔、沸点,相对密度约为 1.50,折光率 1.546。易溶于,微溶于乙醇,不溶于氨水中。加热至 95℃时脱,高温分解出一氧化碳二氧化碳气。能与其它属盐反应生成溶解度较低的草酸盐。例如,在其溶液中加入可溶性盐会形成白色沉淀,也可作为配体与过渡属盐形成草酸类配合物。

制备方法

草酸氨水(或碳酸铵)作用经结晶而得。

用途

草酸铵可用于制备含染料、有机合成原料,并可作测定及稀土属离子的试剂和属抛光剂。

中溶解度(g/100ml)

不同温度下每 100 毫升中的溶解克数如下:

  • 2.2g/0℃
  • 3.21g/10℃
  • 4.45g/20℃
  • 6.09g/30℃
  • 8.18g/40℃
  • 14g/60℃
  • 22.4g/80℃
  • 27.9g/90℃
  • 34.7g/100℃
化学性质

无色柱状结晶。相对密度约为 1.501,折光率约为 1.439。能溶于约 20 份冷和 2.6 份沸中,微溶于乙醇,不溶于中。无气味,在加热时会分解。

用途

用于分析试剂和有机合成中间体。也可用于制备安全炸药及作为分析试剂等用途。在实验室条件下,草酸铵可与溶液中的离子生成沉淀,通过过滤除去溶液中的离子。

生产方法

草酸溶解于中,加入氨水中并不断搅拌,将溶液迅速冷却至 25℃,过滤结晶,在室温下干燥获得草酸铵

类别

有毒物品

毒性分级

高毒

急性毒性

参考值:腹腔-小鼠 LD₅₀: 155 毫克/公斤

可燃性危险特性

可燃;燃烧时产生有毒氮氧化物和烟雾。

储运特性

库房应通风、低温干燥。

灭火剂

干粉、泡沫、砂土、二氧化碳,或用雾状灭火。

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    Dumas, Annales de Chimie (Cachan, France), 1830, vol. <2> 44, p. 133
    摘要:
    DOI:
  • 作为产物:
    描述:
    草酸磷酸二氢铵 作用下, 以 为溶剂, 反应 504.0h, 生成 草酸氢铵(一水)
    参考文献:
    名称:
    半有机草酸氢铵二水合草酸单晶的合成及其表征
    摘要:
    提出了一种用于合成草酸氢铵二水合草酸(NH 4 H 3 (C 4 O 8 )·2H 2 O) 单晶的不同方法。使用溶剂蒸发技术合成晶体。合成的NH 4 H 3 (C 4 O 8 )·2H 2 O单晶通过单晶X射线衍射(SCXRD)、粉末XRD、UV-Vis和光致发光光谱等测量进行了分析,傅里叶变换红外光谱、热重和差热分析 (TG-DTA)、维氏显微硬度测量和电流与电压 (I-V) 特性。SCXRD对晶体分子结构的评价表明,它们属于具有P-1空间群的三斜晶系​​。晶体的结构特性也使用粉末 XRD 测量对其细碎粉末进行评估。这些测量证实了 SCXRD 的结果并证实了晶体的三斜晶系​​。这些晶体的吸光度和发射等光学性质分别使用紫外-可见光和光致发光光谱测定。这些测量表明,晶体在蓝色区域表现出大量发射。使用 TG-DTA 分析研究晶体的热稳定性和分解机理。使用维氏显微硬度技术测定晶体的机械强度。从光依赖的I-V特性分析NH
    DOI:
    10.1007/s10973-020-09965-5
  • 作为试剂:
    描述:
    环辛烷苯乙酮bis(hexafluoroacetylacetonazo)nickel(II)草酸氢铵(一水)bis(trifluoromethane)sulfonimide lithium 作用下, 以 环己烷 为溶剂, 以36%的产率得到4-cyclooctylacetophenone
    参考文献:
    名称:
    一种4-环烷基苯乙酮衍生物的制备方法
    摘要:
    本发明公开了一种4‑环烷基苯乙酮衍生物的制备方法,属于有机化合物技术领域。本发明使用2‑取代苯乙酮衍生物或3‑取代苯乙酮衍生物为起始物,原料易得、种类很多;利用本发明的方法可以一步得到对位环烷基取代的苯乙酮衍生物,产物类型多样,既可以直接使用、又可以用于其他进一步的反应。本发明反应操作和后处理过程简单,产率较高,没有生成大量的金属盐,是绿色、原子经济性高的方法,适合于规模生产。
    公开号:
    CN109020790B
点击查看最新优质反应信息

文献信息

  • Boosting electrochemical water oxidation through replacement of O<sub>h</sub> Co sites in cobalt oxide spinel with manganese
    作者:Prashanth W. Menezes、Arindam Indra、Vitaly Gutkin、Matthias Driess
    DOI:10.1039/c7cc03749j
    日期:——
    The strikingly high catalytic performance and stability of manganese substituted cobalt oxide spinel (MnxCo3-xO4) over pristine cobalt oxide spinel (Co3O4) for the alkaline electrochemical water oxidation is reported. The different role of cations could be uncovered along with the detection of drastic surface-structural changes during the catalysis using spectroscopic and microscopic methods.
    据报道,取代的氧化钴尖晶石(Mn x Co3-xO 4)相对于原始的氧化钴尖晶石(Co 3 O 4)具有极高的催化性能和稳定性,可用于碱性电化学氧化。阳离子的不同作用以及使用光谱和显微镜方法检测催化过程中剧烈的表面结构变化均可发现。
  • The synthesis of quaternary ammonium salts from ammonium salts and dialkyl carbonate
    作者:Zhuoqun Zheng、Tinghua Wu、Xiaoping Zhou
    DOI:10.1039/b601343k
    日期:——
    Quaternary ammonium salts were synthesized from ammonium salts and dialkyl carbonates over an ionic liquid catalyst 1-ethyl-3-methylimidazolium bromide.
    离子液体催化剂化1-乙基-3-甲基咪唑鎓上由盐和碳酸二烷基酯合成季盐。
  • CONVERSION OF 2,3-BUTANEDIOL TO BUTADIENE
    申请人:Battelle Memorial Institute
    公开号:US20150218062A1
    公开(公告)日:2015-08-06
    A composition comprising 2,3-butanediol is dehydrated to methyl vinyl carbinol and/or 1,3-butadiene by exposure to a catalyst comprising (a) M x O y wherein M is a rare earth metal, a group IIIA metal, Zr, or a combination thereof, and x and y are based upon an oxidation state of M, or (b) M 3 a (PO 4 ) b where M 3 is a group IA, a group IIA metal, a group IIIA metal, or a combination thereof, and a and b are based upon the oxidation state of M 3 . Embodiments of the catalyst comprising M x O y may further include M 2 , wherein M 2 is a rare earth metal, a group IIA metal, Zr, Al, or a combination thereof. In some embodiments, 2,3-butanediol is dehydrated to methyl vinyl carbinol and/or 1,3-butadiene by a catalyst comprising M x O y , and the methyl vinyl carbinol is subsequently dehydrated to 1,3-butadiene by exposure to a solid acid catalyst.
    一种包括2,3-丁二醇的组合物通过暴露于催化剂而被脱成为甲基乙烯醇和/或1,3-丁二烯,所述催化剂包括(a) MxOy,其中M是稀土属、III A族属、或二者的组合物,x和y基于M的氧化态,或(b) M3a(PO4)b,其中M3是IA族属、IIA族属、III A族属或二者的组合物,a和b基于M3的氧化态。包括MxOy的催化剂的实施例可能进一步包括M2,其中M2是稀土属、IIA族属、、铝或二者的组合物。在一些实施例中,2,3-丁二醇通过包括MxOy的催化剂被脱成为甲基乙烯醇和/或1,3-丁二烯,然后通过暴露于固体酸催化剂将甲基乙烯醇进一步脱成为1,3-丁二烯
  • Alkylation of Ammonium Salts Catalyzed by Imidazolium-Based Ionic Liquid Catalysts
    作者:Zhuo Qun Zheng、Jie Wang、Ting Hua Wu、Xiao Ping Zhou
    DOI:10.1002/adsc.200600451
    日期:2007.5.7
    Quaternary ammonium salts were synthesized from ammonium salts and dialkyl carbonates over imidazolium ionic liquid catalysts. The reaction gave almost stoichiometric amounts of the quaternary ammonium salts for halides and nitrates. It was found that the electron-donating property of the alkyl moieties of ammonium cations, the electrophilic nature of the alkyl group of the carbonate, the acidity of
    咪唑离子液体催化剂上由盐和碳酸二烷基酯合成季盐。该反应产生了几乎化学计量的用于卤化物和硝酸盐的季盐。发现阳离子的烷基部分的供电子性,碳酸盐烷基的亲电子性质,盐的阴离子所对应的酸的酸度以及的空间位阻。盐和碳酸二烷基酯是影响季盐收率的关键因素。盐氮原子上的强供电子烷基,碳酸二烷基酯的亚甲基碳上的吸电子基团,
  • 1,2,4-Triazole Schiff base directed synthesis of polynuclear iron complexes: Investigating the magnetic properties going from a dimer to a 1D chain to a 3D framework
    作者:Ai-Min Li、Eva Rentschler
    DOI:10.1016/j.poly.2018.08.003
    日期:2018.11
    chain structure and 2 exhibiting a zigzag chain based 3D interpenetrating framework. Both structures show rather big voids in the 3D architecture (∼15% of the crystal volume). Compound (5-imztrzH)2[FeIII2(cit4−)2(H2O)2]·6H2O (3) is a binuclear FeIII complex bridging by two citrate ligands to form a face-shared centrosymmetric structure. Magnetic susceptibility measurements indicate that all three compounds
    摘要基于两个功能化的席夫碱配体4-(1H-咪唑-5-基亚甲基-基)-4H-1,2,4-三唑(imztrz)和4-(对甲苯基-基)-4H-1,2制备了一系列的三种基于三唑的多核配合物-4-三唑(toltrz)。化合物[FeII(toltrz)2(C2O4)]·10H2O} n(1)和[FeII(5-imztrz)( )]·2H2O} n(2)是草酸盐桥连的FeII配合物,其中1显示线性1D链结构和2展示了基于锯齿形链的3D互穿框架。两种结构在3D结构中都显示出相当大的空隙(约为晶体体积的15%)。化合物(5-imztrzH)2 [FeIII 2(cit 4-)2(H 2 O)2]·6H 2 O(3)是通过两个柠檬酸配体桥接形成面共享的中心对称结构的双核FeIII络合物。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸